Latest share price

Current

666.90p

Average

-2.60p LSE

-0.39% 15 min delay

View chart

Results, reports & presentations

Our financial reports, corporate presentations, webcasts and audio can be found in this section.

Go

Latest press releases

25/10/2018

Oxford BioMedica notes that Axovant doses first patient in clinical study of...

Read more

05/10/2018

Oxford BioMedica announces additional details of its strategic alliance with...

Read more

13/09/2018

Oxford BioMedica announces further capacity expansion with new facility

Read more

See all

Regulatory news

Message from the CEO
John Dawson

 

Message from the CEO 
John Dawson

Management and DirectorsGo

Shareholder meetings, circulars, and prospectusesGo

Analyst coverageGo

Corporate governanceGo

Financial calendarGo

Investor contactsGo

Email alertsGo